CoChat

The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus

Open access
Garrison, Aura R., Giomarelli, Barbara G., Lear-Rooney, Calli M., Saucedo, Carrie J., Yellayi, Srikanth, Krumpe, Lauren R.H., Rose, Maura, Paragas, Jason, Bray, Mike, Olinger, Gene G., McMahon, James B., Huggins, John, O’Keefe, Barry R. · 2014 · Antiviral Research
Cited by 90

The DOI matches its Crossref record.

Abstract

The cyanobacterial lectin scytovirin (SVN) binds with high affinity to mannose-rich oligosaccharides on the envelope glycoprotein (GP) of a number of viruses, blocking entry into target cells. In this study, we assessed the ability of SVN to bind to the envelope GP of Zaire Ebola virus (ZEBOV) and inhibit its replication. SVN interacted specifically with the protein’s mucin-rich domain. In cell culture, it inhibited ZEBOV replication with a 50% virus-inhibitory concentration (EC50) of 50 nM, and was also active against the Angola strain of the related Marburg virus (MARV), with a similar EC50. Injected subcutaneously in mice, SVN reached a peak plasma level of 100 nm in 45 minutes, but was cleared within 4 hours. When ZEBOV-infected mice were given 30 mg/kg/day of SVN by subcutaneous injection every 6 hours, beginning the day before virus challenge, 9 of 10 animals survived the infection, while all infected, untreated mice died. When treatment was begun one hour or one day after challenge, 70-90% of mice survived. Quantitation of infectious virus and viral RNA in samples of serum, liver and spleen collected on days 2 and 5 postinfection showed a trend toward lower titers in treated than control mice, with a significant decrease in liver titers on day 2. Our findings provide further evidence of the potential of natural lectins as therapeutic agents for viral infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.antiviral.2014.09.012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 90

Metadata

Authors
Garrison, A. R., Giomarelli, B. G., Lear-Rooney, C. M., Saucedo, C. J., Yellayi, S., Krumpe, L. R. H., Rose, M., Paragas, J., Bray, M., Olinger, G. G., McMahon, J. B., Huggins, J., & O’Keefe, B. R.
Venue
Antiviral Research
Publisher
Elsevier BV
Published
2014-12
Volume
112
Pages
1-7
ISSN
0166-3542 (ISSN-L)
OpenAlex
W2087614845
Cited by
90
References
0
FWCI
4.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. https://app.cochat.ai/papers/10.1016/j.antiviral.2014.09.012
The paper
Garrison, A. R., Giomarelli, B. G., Lear-Rooney, C. M., Saucedo, C. J., Yellayi, S., Krumpe, L. R. H., Rose, M., Paragas, J., Bray, M., Olinger, G. G., McMahon, J. B., Huggins, J., & O’Keefe, B. R. (2014). The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Research. https://doi.org/10.1016/j.antiviral.2014.09.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.